Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials Network

Paul A. Carpenter(Fred Hutch Cancer Center), Mukta Arora(Fairview Health Services), Luciano J. Costa(University of Alabama at Birmingham), Aleksandr Lazaryan(Moffitt Cancer Center), Edmund K. Waller(Emory University), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Corey Cutler(Harvard University), Stephanie J. Lee(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Amin M. Alousi(McGill University), Eneida R. Nemecek(Oregon Health & Science University), Laura Johnston(Stanford Medicine), Adam Mendizabal(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Steven Z. Pavletic(National Institutes of Health), Carrie L. Kitko(Vanderbilt University Medical Center), Daniel J. Weisdorf(University of Minnesota), Sunil Abhyankar(University of Kansas Medical Center), Mary M. Horowitz(Medical College of Wisconsin), Shelly L. Carter(Emmes (United States)), Yanli Wang(Stanford University), Javier Bolaños‐Meade(Johns Hopkins University)
Transplantation and Cellular Therapy
February 18, 2016
Cited by 5


Related Papers